Highlights Hydromer, Inc.

Equities

HYDI

US4490011065

Market Closed - Nyse Other stock markets 15:54:25 14/05/2024 BST			5-day change	1st Jan Change
0.35 ^USD	-35.19%		0.00%	+89.19%

01-16	Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023	CI
01-16	Hydromer, Inc. Revises Fiscal Year from June 30 to December 31	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hydromer, Inc. Announces the Relaunch of its Legendary SeaSlide?? Hydrophilic Watercraft Coating	01-16	CI
Hydromer, Inc. Announces That New Facility in North Carolina Is Fully Operational with Extensive New Capabilities	23/09/21	CI
Hydromer Selected as Key Coatings Provider for Avinger’s Image-Guided PAD Therapeutic Devices	20/05/21	CI
Hydromer Inc Signs Agreement to Sell Their Hand and Surface Sanitizer Lines, Hydromer First Responder, HydroProtect and EscenciaProtect on the Stockd e-Commerce Marketplace	03/12/20	CI
Hydromer as the Exclusive Coatings Partner for N8 Announces the CeraShield Coating Has Demonstrated the Ability to Inhibit and Reduce the Growth of Covid-19 Virus on Tube Surfaces	18/08/20	CI
Hydromer Accelerates Its First Responder Sanitizer Production to Meet Growing Demand	30/04/20	CI
Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients	24/04/20	CI
N8 Medical, LLC Partners with Hydromer Inc. and Biosearch Medical Products, Inc for Material Supply and Production of the CeraShield	23/04/20	CI
Hydromer Enters into New Commercial Relationship Agreements with Multiple Clients to Kick-Off the New Year 2020	14/01/20	CI
Hydromer Inc. Announces its Partnership With EuroDev to Expand on Demand for its Specialty Coatings Products in Europe	06/11/19	CI
Hydromer Inc. Announces the Launch of Its Next Generation Website to Provide Clients with A Better User Experience	12/07/19	CI
Hydromer Inc. Announces Advancement of Manufacturing Capabilities with Relocation to North Carolina	24/04/19	CI
Hydromer, Inc. Announces Dividend, Payable on October 8, 2018	19/09/18	CI
Huvepharma AD acquired T-HEXX animal healthcare business of Hydromer, Inc. for $6.5 million.	27/08/18	CI
Hydromer, Inc. Presents New Technology Based on Its US Patent on Antimicrobial Formulations and Methods for Sanitizing Meat Products	26/07/18	CI
Hydromer Inc. Enters into Two License Agreements	02/09/16	CI
Hydromer Inc. Enters into an Exclusive License Agreement with Ortopro AS for Implantable Orthopedic Devices	07/03/13	CI
Hydromer Inc. Enters into Medical Coating Licenses with Two International Medical Device Companies	26/02/13	CI
Hydromer, Inc. Enters into Two Royalty Bearing Medical Coating Licenses in August 2012	10/09/12	CI
Hydromer Inc. Enters into Strategic Development Agreement with N8 Medical, LLC for New Class of Antimicrobial Coatings	28/06/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hydromer, Inc.

Equities

HYDI

US4490011065

Highlights

Filters